Why IMU is a multi multi bagger, page-22278

Are those listed on the table at the same early stage as CF33 or are they all much further down the clinical trial stage? Did they also see as excellent efficacy early in Ph1 which is very rare? Did RAC see such excellent efficacy in early Ph1?

"The complete response is excellent for IMU and CF33"
"The clinical efficacy has been significantly less than hoped for, so IMU management are attempting a higher dosing regimen in the hope that they find more responses."

Aren't you contradicting yourself with these 2 statements and you should know the primary endpoint of Ph1 is about safety to start at a very low dosage and then increase to find the maximum dosage so that was a very disingenuous comment by you.


"I will stay tuned"

Sure you will, just like you stayed tune when the pps reached as low as 4c before the interim clinical update for CF33.